These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 2957187

  • 1. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci.
    Ravizzola G, Pirali F, Foresti I, Turano A.
    Drugs Exp Clin Res; 1987; 13(4):225-9. PubMed ID: 2957187
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
    Jensen KT, Schønheyder H, Pers C, Thomsen VF.
    APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
    [Abstract] [Full Text] [Related]

  • 3. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC, Ribou G, Masquelier B.
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [Abstract] [Full Text] [Related]

  • 4. [Bactericidal effect of daptomycin (LY 146032) compared with vancomycine and teicoplanin against gram-positive bacteria].
    Caillon J, Juvin ME, Pirault JL, Drugeon HB.
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):540-8. PubMed ID: 2552378
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of in vitro activity of teicoplanin against recent clinical isolates.
    Nani E, Amato G, Anzivino D, Covelli B, Lembo M.
    Chemioterapia; 1988 Feb; 7(1):20-3. PubMed ID: 2967737
    [Abstract] [Full Text] [Related]

  • 6. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y, Hasçelik G, Gür D, Akalin E.
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.
    Gales AC, Sader HS, Jones RN.
    Clin Microbiol Infect; 2005 Feb; 11(2):95-100. PubMed ID: 15679482
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 9. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [Abstract] [Full Text] [Related]

  • 10. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS, Pavlov AY, Olsufyeva EN, Mirchink EP, Preobrazhenskaya MN.
    J Med Chem; 2003 Mar 27; 46(7):1204-9. PubMed ID: 12646030
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S, Tebbs SE, Elliott TS.
    J Antimicrob Chemother; 1998 Feb 27; 41(2):273-6. PubMed ID: 9533471
    [Abstract] [Full Text] [Related]

  • 12. The bactericidal activity of vancomycin and teicoplanin against Streptococcus pneumoniae.
    Felmingham D, Foxall P, O'Hare M, Grüneberg R.
    Scand J Infect Dis Suppl; 1990 Feb 27; 72():20-5. PubMed ID: 2151062
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocci.
    Gorzynski EA, Amsterdam D, Beam TR, Rotstein C.
    Antimicrob Agents Chemother; 1989 Nov 27; 33(11):2019-22. PubMed ID: 2532875
    [Abstract] [Full Text] [Related]

  • 14. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM, Ishag AH, Durgham SM.
    APMIS Suppl; 1988 Nov 27; 3():68-70. PubMed ID: 2972301
    [Abstract] [Full Text] [Related]

  • 15. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F, Aguilar L, González N, Giménez MJ, Torrico M, Alou L, Sevillano D, Vallejo P, Prieto J.
    J Antimicrob Chemother; 2007 Jun 27; 59(6):1185-9. PubMed ID: 17412725
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
    Debbia E, Schito GC, Nicoletti G, Speciale A.
    Chemioterapia; 1987 Oct 27; 6(5):319-23. PubMed ID: 3480779
    [Abstract] [Full Text] [Related]

  • 17. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb 27; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of ciprofloxacin against gram-positive cocci.
    Barry AL, Jones RN.
    Am J Med; 1987 Apr 27; 82(4A):27-32. PubMed ID: 3578323
    [Abstract] [Full Text] [Related]

  • 19. Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria.
    King A, Phillips I, Kaniga K.
    J Antimicrob Chemother; 2004 May 27; 53(5):797-803. PubMed ID: 15028667
    [Abstract] [Full Text] [Related]

  • 20. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
    Biavasco F, Vignaroli C, Lupidi R, Manso E, Facinelli B, Varaldo PE.
    Antimicrob Agents Chemother; 1997 Oct 27; 41(10):2165-72. PubMed ID: 9333042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.